GS

Geeta Singh

Active Director Director DIN 06813687
DIN 06813687 First appointment Feb 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value •••• Premium profile

About Geeta Singh

Data last updated:

Geeta Singh is a Director at Gp Rules Pharmaceuticals Private Limited (since 2014). The company operates in Trading. Gp Rules Pharmaceuticals Private Limited reported revenue of ₹6,000 (FY 2026).

DIN 06813687
Primary Designation Director
Industry Trading
First Appointment 25 Feb 2014
Oldest Company Age 12 yrs
Largest company Gp Rules Pharmaceuticals Private Limited · ₹6,000 (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20142014₹6,000 (FY 2026)Active

Board colleagues of Geeta Singh

NameDINCompanyDesignation
Pradeep Kumar Singh01746925Gp Rules Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gp Rules Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Geeta Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Singh

Geeta Singh currently holds 1 directorship: Gp Rules Pharmaceuticals Private Limited (Director, since 25 Feb 2014, revenue ₹6,000 (FY 2026)).

Geeta Singh was first appointed on 25 Feb 2014 as Director at Gp Rules Pharmaceuticals Private Limited.

The current boards of Geeta Singh's companies include Pradeep Kumar Singh (Gp Rules Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available